Trifecta Capital Advisors, LLC
Position in VRTX — Vertex Pharmaceuticals Inc / Ma
CIK 1962615
NORTHBROOK, IL
Position in VRTX
as of Mar 31, 2026
· filed May 1, 2026
Position Value
$7,482,670
+$3,591 QoQ
Shares Held
16,757
+1.6% QoQ
Ownership
0.007%
of shares outstanding
% of Portfolio
1.41%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Dec 2022
14 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in VRTX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026Trifecta Capital Advisors, LLC holds $7,561,020 across 4 Biotechnology names. VRTX ranks #1 (99.0% of the industry book) .
All Filings in VRTX
Export CSV
14 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $7,482,670 | 16,757 | Shares | Sole | 2026-05-01 | |
| 2025-12-31 | $7,479,079 | 16,497 | Shares | Sole | 2026-01-30 | |
| 2025-09-30 | $6,200,836 | 15,833 | Shares | Sole | 2025-11-03 | |
| 2025-06-30 | $6,829,368 | 15,340 | Shares | Sole | 2025-07-23 | |
| 2025-03-31 | $7,048,313 | 14,538 | Shares | Sole | 2025-04-21 | |
| 2024-12-31 | $5,623,705 | 13,965 | Shares | Sole | 2025-02-04 | |
| 2024-09-30 | $6,294,857 | 13,535 | Shares | Sole | 2024-10-16 | |
| 2024-06-30 | $6,241,475 | 13,316 | Shares | Sole | 2024-08-07 | |
| 2024-03-31 | $5,167,021 | 12,361 | Shares | Sole | 2024-04-16 | |
| 2023-12-31 | $4,815,543 | 11,835 | Shares | Sole | 2024-01-25 | |
| 2023-09-30 | $3,993,793 | 11,485 | Shares | Sole | 2023-11-01 | |
| 2023-06-30 | $3,800,628 | 10,800 | Shares | Sole | 2023-08-14 | |
| 2023-03-31 | $3,090,836 | 9,810 | Shares | Sole | 2023-05-09 | |
| 2022-12-31 | $1,313,949 | 4,550 | Shares | Sole | 2023-01-18 | |
| No filing history on record for this holder in this stock. | ||||||